EGFR and Interstitial pneumonitis: According to our study results, it is worth administering EGFR-TKIs for patients who are detected as EGFR mutation while they are undergoing MV in ICU, and TKI should be withheld if there is any suspicion of TKI-related interstitial pneumonitis clinically.